Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dexketoprofen/dicycloverine - Emcure Pharmaceuticals

Next Previous
Search
Drug Profile

Dexketoprofen/dicycloverine - Emcure Pharmaceuticals

Alternative Names: Dexketoprofen trometamol/dicycloverine; Dexketoprofen/dicyclomine; Dicycloverine/dexketoprofen trometamol; DXD; Infen Spas

Latest Information Update: 29 Mar 2019

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Emcure Pharmaceuticals
  • Class Antispasmodics; Nonsteroidal anti-inflammatories; Phenylpropionates; Propylene glycols; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors; Muscarinic receptor antagonists; S100 protein antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Acute pain

Most Recent Events

  • 29 Mar 2019 Chemical structure information added
  • 20 Apr 2016 Launched for Acute pain in India (IM) before April 2016
  • 22 Sep 2010 Phase-III clinical trials in Acute pain in India (IM)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top